Date:02-May-2024  Time: 4:41 AM
 
 
        
Glaxosmithkline Pharmaceuticals Ltd
(Rs. In Crores)
ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Share Capital 169.41169.41169.41169.41169.41
Reserves & Surplus 1583.592508.211327.711670.631973.01
Total Shareholders Funds1753.002677.621497.121840.042142.42
Secured Loans 0.000.000.000.000.00
Unsecured Loans 269.76283.08294.92289.57316.30
Total Debt269.76283.08294.92289.57316.30
Total Liabilities2022.762960.701792.042129.612458.72
Gross Block 635.93593.89602.891454.59561.30
Less: Accum. Depreciation305.99263.26216.00696.53129.69
Net Block329.94330.63386.89758.06431.61
Capital Work in Progress20.3130.5013.21120.121002.64
Investments 542.78390.0924.4924.4924.55
Inventories 437.70512.71523.34483.03486.49
Sundry Debtors 192.38205.24215.6099.80120.49
Cash and Bank Balance 1150.732479.111157.681066.411155.33
Loans and Advances 672.06693.20791.43596.85712.19
Total Current Assets2452.873890.262688.052246.092474.50
Current Liabilities 609.141065.42882.27577.111229.27
Provisions 713.99615.36438.35442.04245.32
Total Current Liabilities1323.131680.781320.621019.151474.59
Net Current Assets1129.742209.481367.431226.94999.91
Miscellaneous Expenses not w/o 0.000.000.000.000.00
Total Assets2022.772960.701792.022129.612458.71
Contingent Liabilities 350.59351.10485.78471.42512.80
 
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com